DIGITALISATION OF PHARMA 4.0 OPERATIONS

“Digitalisation in the Pharmaceutical, Cosmetics and Biotechnology sector”

BARCELONA (QGAT) 2020

On 6/10/2020 in Barcelona, Oytec held an event especially dedicated to end customers in the Pharmaceutical, Biotechnology and Cosmetics sector to showcase the latest technological advances.

A number of presentations were given, explaining the different trends in the management of plant operations, with a focus on the implementation of electronic batch records and their impact on company structure; from the impact on people to the technical and regulatory implementation required to carry out the project.

We were fortunate to have the invaluable collaboration of several speakers, who showed the way forward so that projects of this kind can be implemented with the greatest guarantees of return on investment.

QbD – Alicia Tebar

Alicia Tebar from QbD showed us the path towards incorporating the scientific knowledge needed to model, automate and ultimately digitalise the manufacturing process, in order to continue meeting quality standards while clearly increasing efficiency and productivity. ICH Q12 was presented, which proposes new models for managing the relationship between manufacturers and regulatory agencies in order to enable this evolution.

INSUDPHARMA – Cesar Quintana

Cesar Quintana from InsudPharma told us how they carried out the strategic decision to digitalise the value chain, in particular the entire management of plant operations, affecting every area and department of the plant. He also showed us the impact of “Comprehensive Digitalisation Strategies” focused on the Electronic Batch Record (EBR), Digital Lean and electronic production sequencing.

AIZON – Cristian Marfà

The company Aizon, with Cristian Marfà, explained the increasingly pressing need to start improving efficiency in the pharmaceutical industry. There are no more scientific excuses for not adopting AI/ML technology. People need to change their mindset and start with a practical approach to incorporating these powerful AI tools and the compelling benefits they offer. And perhaps one key to this change of mindset is simply a matter of better understanding the capabilities of these technologies and how they work, so that AI models can ultimately be verified in line with the regulators.

SIEMENS – Jan Verelest

Also, with Jan Verelest from SIEMENS, we showed how digitalisation is increasingly shaping our daily lives, with technology that often brings greater convenience to our activities, and we regard this as a natural evolution. It should come as no surprise that digitalisation is also entering the pharmaceutical industry and gradually changing the way we develop and produce medicines and pharmaceutical products. This process has already begun and will certainly continue to expand; we focused on the digitalisation of quality control management and how this could evolve further in the future, impacting the control strategy for pharmaceutical processes.

OYTEC- Joan Valls | Jordi Pujadó

Also taking part in the event were Joan Valls, Manager of Oytec , who discussed the advantages of implementing an electronic batch record as a solution to increasing regulatory pressure, together with Jordi Pujado, Technical Manager of Oytec, who spoke to us about the key element of digital transformation: people.

OYTEC – Jordi Codina

To round off the event, Jordi Codina, EBR/MES Consultant at Oytec, demonstrated the execution of an eBR Electronic Batch Record, showing the full operational and functional management: Materials Management, Equipment, Logbooks, Weighing operations, Review by Exception, among others.